Skip to main content
Top
Published in: BMC Nephrology 1/2010

Open Access 01-12-2010 | Research article

The relation of C - reactive protein to chronic kidney disease in African Americans: the Jackson Heart Study

Authors: Ervin R Fox, Emelia J Benjamin, Daniel F Sarpong, Harsha Nagarajarao, Jason K Taylor, Michael W Steffes, Abdullah K Salahudeen, Michael F Flessner, Ermeg L Akylbekova, Caroline S Fox, Robert J Garrison, Herman A Taylor Jr

Published in: BMC Nephrology | Issue 1/2010

Login to get access

Abstract

Background

African Americans have an increased incidence and worse prognosis with chronic kidney disease (CKD - estimated glomerular filtration rate [eGFR] <60 ml/min/1.73 m2) than their counterparts of European-descent. Inflammation has been related to renal disease in non-Hispanic whites, but there are limited data on the role of inflammation in renal dysfunction in African Americans in the community.

Methods

We examined the cross-sectional relation of log transformed C-reactive protein (CRP) to renal function (eGFR by Modification of Diet and Renal Disease equation) in African American participants of the community-based Jackson Heart Study's first examination (2000 to 2004). We conducted multivariable linear regression relating CRP to eGFR adjusting for age, sex, body mass index, systolic and diastolic blood pressure, diabetes, total/HDL cholesterol, triglycerides, smoking, antihypertensive therapy, lipid lowering therapy, hormone replacement therapy, and prevalent cardiovascular disease events. In a secondary analysis we assessed the association of CRP with albuminuria (defined as albumin-to-creatinine ratio > 30 mg/g).

Results

Participants (n = 4320, 63.2% women) had a mean age ± SD of 54.0 ± 12.8 years. The prevalence of CKD was 5.2% (n = 228 cases). In multivariable regression, CRP concentrations were higher in those with CKD compared to those without CKD (mean CRP 3.2 ± 1.1 mg/L vs. 2.4 ± 1.0 mg/L, respectively p < 0.0001). CRP was significantly associated with albuminuria in sex and age adjusted model however not in the multivariable adjusted model (p > 0.05).

Conclusion

CRP was associated with CKD however not albuminuria in multivariable-adjusted analyses. The study of inflammation in the progression of renal disease in African Americans merits further investigation.
Appendix
Available only for authorised users
Literature
1.
go back to reference Tarver-Carr ME, Powe NR, Eberhardt MS, et al: Excess risk of chronic kidney disease among African-American versus white subjects in the United States: a population-based study of potential explanatory factors. J Am Soc Nephrol. 2002, 13 (9): 2363-70. 10.1097/01.ASN.0000026493.18542.6A.CrossRefPubMed Tarver-Carr ME, Powe NR, Eberhardt MS, et al: Excess risk of chronic kidney disease among African-American versus white subjects in the United States: a population-based study of potential explanatory factors. J Am Soc Nephrol. 2002, 13 (9): 2363-70. 10.1097/01.ASN.0000026493.18542.6A.CrossRefPubMed
2.
go back to reference Stam F, van Guldener C, Schalkwijk CG, ter Wee PM, Donker AJ, Stehouwer CD: Impaired renal function is associated with markers of endothelial dysfunction and increased inflammatory activity. Nephrol Dial Transplant. 2003, 18 (5): 892-8. 10.1093/ndt/gfg080.CrossRefPubMed Stam F, van Guldener C, Schalkwijk CG, ter Wee PM, Donker AJ, Stehouwer CD: Impaired renal function is associated with markers of endothelial dysfunction and increased inflammatory activity. Nephrol Dial Transplant. 2003, 18 (5): 892-8. 10.1093/ndt/gfg080.CrossRefPubMed
3.
go back to reference Shlipak MG, Fried LF, Crump C, et al: Elevations of inflammatory and procoagulant biomarkers in elderly persons with renal insufficiency. Circulation. 2003, 107 (1): 87-92. 10.1161/01.CIR.0000042700.48769.59.CrossRefPubMed Shlipak MG, Fried LF, Crump C, et al: Elevations of inflammatory and procoagulant biomarkers in elderly persons with renal insufficiency. Circulation. 2003, 107 (1): 87-92. 10.1161/01.CIR.0000042700.48769.59.CrossRefPubMed
4.
go back to reference Saraheimo M, Teppo AM, Forsblom C, Fagerudd J, Groop PH: Diabetic nephropathy is associated with low-grade inflammation in Type 1 diabetic patients. Diabetologia. 2003, 46 (10): 1402-7. 10.1007/s00125-003-1194-5.CrossRefPubMed Saraheimo M, Teppo AM, Forsblom C, Fagerudd J, Groop PH: Diabetic nephropathy is associated with low-grade inflammation in Type 1 diabetic patients. Diabetologia. 2003, 46 (10): 1402-7. 10.1007/s00125-003-1194-5.CrossRefPubMed
5.
go back to reference Stuveling EM, Hillege HL, Bakker SJ, Gans RO, De Jong PE, De Zeeuw D: C-reactive protein is associated with renal function abnormalities in a non-diabetic population. Kidney Int. 2003, 63 (2): 654-61. 10.1046/j.1523-1755.2003.00762.x.CrossRefPubMed Stuveling EM, Hillege HL, Bakker SJ, Gans RO, De Jong PE, De Zeeuw D: C-reactive protein is associated with renal function abnormalities in a non-diabetic population. Kidney Int. 2003, 63 (2): 654-61. 10.1046/j.1523-1755.2003.00762.x.CrossRefPubMed
6.
go back to reference Teppo AM, Tornroth T, Honkanen E, Gronhagen-Riska C: Elevated serum C-reactive protein associates with deterioration of renal function in transplant recipients. Clin Nephrol. 2003, 60 (4): 248-56.CrossRefPubMed Teppo AM, Tornroth T, Honkanen E, Gronhagen-Riska C: Elevated serum C-reactive protein associates with deterioration of renal function in transplant recipients. Clin Nephrol. 2003, 60 (4): 248-56.CrossRefPubMed
7.
go back to reference Astor BC, Hallan SI, Miller ER, Yeung E, Coresh J: Glomerular filtration rate, albuminuria, and risk of cardiovascular and all-cause mortality in the US population. Am J Epidemiol. 2008, 167 (10): 1226-34. 10.1093/aje/kwn033.CrossRefPubMed Astor BC, Hallan SI, Miller ER, Yeung E, Coresh J: Glomerular filtration rate, albuminuria, and risk of cardiovascular and all-cause mortality in the US population. Am J Epidemiol. 2008, 167 (10): 1226-34. 10.1093/aje/kwn033.CrossRefPubMed
8.
go back to reference Palmas W, Ma S, Jacobs DR, et al: Ethnicity and sex modify the association of serum c-reactive protein with microalbuminuria. Ethn Dis. 2008, 18 (3): 324-9.PubMedPubMedCentral Palmas W, Ma S, Jacobs DR, et al: Ethnicity and sex modify the association of serum c-reactive protein with microalbuminuria. Ethn Dis. 2008, 18 (3): 324-9.PubMedPubMedCentral
9.
go back to reference Taylor HA, Wilson JG, Jones DW, et al: Toward resolution of cardiovascular health disparities in African Americans: design and methods of the Jackson Heart Study. Ethn Dis. 2005, 15 (4 Suppl 6): S6-17. Taylor HA, Wilson JG, Jones DW, et al: Toward resolution of cardiovascular health disparities in African Americans: design and methods of the Jackson Heart Study. Ethn Dis. 2005, 15 (4 Suppl 6): S6-17.
10.
go back to reference Fuqua SR, Wyatt SB, Andrew ME, et al: Recruiting African-American research participation in the Jackson Heart Study: methods, response rates, and sample description. Ethn Dis. 2005, 15 (4 Suppl 6): S6-29.PubMed Fuqua SR, Wyatt SB, Andrew ME, et al: Recruiting African-American research participation in the Jackson Heart Study: methods, response rates, and sample description. Ethn Dis. 2005, 15 (4 Suppl 6): S6-29.PubMed
11.
go back to reference Wilson JG, Rotimi CN, Ekunwe L, et al: Study design for genetic analysis in the Jackson Heart Study. Ethn Dis. 2005, 15 (4 Suppl 6): S6-37. Wilson JG, Rotimi CN, Ekunwe L, et al: Study design for genetic analysis in the Jackson Heart Study. Ethn Dis. 2005, 15 (4 Suppl 6): S6-37.
12.
go back to reference Menon V, Wang X, Greene T, et al: Relationship between C-reactive protein, albumin, and cardiovascular disease in patients with chronic kidney disease. Am J Kidney Dis. 2003, 42 (1): 44-52. 10.1016/S0272-6386(03)00407-4.CrossRefPubMed Menon V, Wang X, Greene T, et al: Relationship between C-reactive protein, albumin, and cardiovascular disease in patients with chronic kidney disease. Am J Kidney Dis. 2003, 42 (1): 44-52. 10.1016/S0272-6386(03)00407-4.CrossRefPubMed
13.
go back to reference Coresh J, Astor BC, Greene T, Eknoyan G, Levey AS: Prevalence of chronic kidney disease and decreased kidney function in the adult US population: Third National Health and Nutrition Examination Survey. Am J Kidney Dis. 2003, 41 (1): 1-12. 10.1053/ajkd.2003.50007.CrossRefPubMed Coresh J, Astor BC, Greene T, Eknoyan G, Levey AS: Prevalence of chronic kidney disease and decreased kidney function in the adult US population: Third National Health and Nutrition Examination Survey. Am J Kidney Dis. 2003, 41 (1): 1-12. 10.1053/ajkd.2003.50007.CrossRefPubMed
14.
go back to reference Levey AS, Coresh J, Balk E, et al: National Kidney Foundation practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Ann Intern Med. 2003, 139 (2): 137-47.CrossRefPubMed Levey AS, Coresh J, Balk E, et al: National Kidney Foundation practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Ann Intern Med. 2003, 139 (2): 137-47.CrossRefPubMed
15.
go back to reference Flessner MF, Wyatt SB, Akylbekova EL, et al: Prevalence and awareness of CKD among African Americans: the Jackson Heart Study. Am J Kidney Dis. 2009, 53 (2): 238-47. 10.1053/j.ajkd.2008.08.035.CrossRefPubMedPubMedCentral Flessner MF, Wyatt SB, Akylbekova EL, et al: Prevalence and awareness of CKD among African Americans: the Jackson Heart Study. Am J Kidney Dis. 2009, 53 (2): 238-47. 10.1053/j.ajkd.2008.08.035.CrossRefPubMedPubMedCentral
16.
go back to reference Chobanian AV, Bakris GL, Black HR, et al: The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. JAMA. 2003, 289 (19): 2560-72. 10.1001/jama.289.19.2560.CrossRefPubMed Chobanian AV, Bakris GL, Black HR, et al: The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. JAMA. 2003, 289 (19): 2560-72. 10.1001/jama.289.19.2560.CrossRefPubMed
17.
go back to reference Genuth S, Alberti KG, Bennett P, et al: Follow-up report on the diagnosis of diabetes mellitus. Diabetes Care. 2003, 26 (11): 3160-7. 10.2337/diacare.26.11.3160.CrossRefPubMed Genuth S, Alberti KG, Bennett P, et al: Follow-up report on the diagnosis of diabetes mellitus. Diabetes Care. 2003, 26 (11): 3160-7. 10.2337/diacare.26.11.3160.CrossRefPubMed
18.
go back to reference Pearson TA, Mensah GA, Alexander RW, et al: Markers of inflammation and cardiovascular disease: application to clinical and public health practice: A statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Heart Association. Circulation. 2003, 107 (3): 499-511. 10.1161/01.CIR.0000052939.59093.45.CrossRefPubMed Pearson TA, Mensah GA, Alexander RW, et al: Markers of inflammation and cardiovascular disease: application to clinical and public health practice: A statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Heart Association. Circulation. 2003, 107 (3): 499-511. 10.1161/01.CIR.0000052939.59093.45.CrossRefPubMed
19.
go back to reference Coresh J, Selvin E, Stevens LA, et al: Prevalence of chronic kidney disease in the United States. JAMA. 2007, 298 (17): 2038-47. 10.1001/jama.298.17.2038.CrossRefPubMed Coresh J, Selvin E, Stevens LA, et al: Prevalence of chronic kidney disease in the United States. JAMA. 2007, 298 (17): 2038-47. 10.1001/jama.298.17.2038.CrossRefPubMed
20.
go back to reference Weiss MF, Rodby RA, Justice AC, Hricik DE: Free pentosidine and neopterin as markers of progression rate in diabetic nephropathy. Collaborative Study Group. Kidney Int. 1998, 54 (1): 193-202.CrossRefPubMed Weiss MF, Rodby RA, Justice AC, Hricik DE: Free pentosidine and neopterin as markers of progression rate in diabetic nephropathy. Collaborative Study Group. Kidney Int. 1998, 54 (1): 193-202.CrossRefPubMed
21.
go back to reference Myrup B, de Maat M, Rossing P, Gram J, Kluft C, Jespersen J: Elevated fibrinogen and the relation to acute phase response in diabetic nephropathy. Thromb Res. 1996, 81 (4): 485-90. 10.1016/0049-3848(96)00021-7.CrossRefPubMed Myrup B, de Maat M, Rossing P, Gram J, Kluft C, Jespersen J: Elevated fibrinogen and the relation to acute phase response in diabetic nephropathy. Thromb Res. 1996, 81 (4): 485-90. 10.1016/0049-3848(96)00021-7.CrossRefPubMed
22.
go back to reference Fried L, Solomon C, Shlipak M, et al: Inflammatory and prothrombotic markers and the progression of renal disease in elderly individuals. J Am Soc Nephrol. 2004, 15 (12): 3184-91. 10.1097/01.ASN.0000146422.45434.35.CrossRefPubMed Fried L, Solomon C, Shlipak M, et al: Inflammatory and prothrombotic markers and the progression of renal disease in elderly individuals. J Am Soc Nephrol. 2004, 15 (12): 3184-91. 10.1097/01.ASN.0000146422.45434.35.CrossRefPubMed
23.
go back to reference Knight EL, Rimm EB, Pai JK, et al: Kidney dysfunction, inflammation, and coronary events: a prospective study. J Am Soc Nephrol. 2004, 15 (7): 1897-903. 10.1097/01.ASN.0000128966.55133.69.CrossRefPubMed Knight EL, Rimm EB, Pai JK, et al: Kidney dysfunction, inflammation, and coronary events: a prospective study. J Am Soc Nephrol. 2004, 15 (7): 1897-903. 10.1097/01.ASN.0000128966.55133.69.CrossRefPubMed
24.
go back to reference Westhuyzen J, Healy H: Review: Biology and relevance of C-reactive protein in cardiovascular and renal disease. Ann Clin Lab Sci. 2000, 30 (2): 133-43.PubMed Westhuyzen J, Healy H: Review: Biology and relevance of C-reactive protein in cardiovascular and renal disease. Ann Clin Lab Sci. 2000, 30 (2): 133-43.PubMed
25.
go back to reference Healy H, Reith D, Morgan C, Clague A, Westhuyzen J: Are metalloproteins and acute phase reactants associated with cardiovascular disease in end-stage renal failure?. Ann Clin Lab Sci. 2000, 30 (3): 295-304.PubMed Healy H, Reith D, Morgan C, Clague A, Westhuyzen J: Are metalloproteins and acute phase reactants associated with cardiovascular disease in end-stage renal failure?. Ann Clin Lab Sci. 2000, 30 (3): 295-304.PubMed
26.
go back to reference Trachtman H, Futterweit S, Arzberger C, et al: Nitric oxide and superoxide in rat mesangial cells: modulation by C-reactive protein. Pediatr Nephrol. 2006, 21 (5): 619-26. 10.1007/s00467-006-0066-x.CrossRefPubMed Trachtman H, Futterweit S, Arzberger C, et al: Nitric oxide and superoxide in rat mesangial cells: modulation by C-reactive protein. Pediatr Nephrol. 2006, 21 (5): 619-26. 10.1007/s00467-006-0066-x.CrossRefPubMed
27.
go back to reference Vigushin DM, Pepys MB, Hawkins PN: Metabolic and scintigraphic studies of radioiodinated human C-reactive protein in health and disease. J Clin Invest. 1993, 91 (4): 1351-7. 10.1172/JCI116336.CrossRefPubMedPubMedCentral Vigushin DM, Pepys MB, Hawkins PN: Metabolic and scintigraphic studies of radioiodinated human C-reactive protein in health and disease. J Clin Invest. 1993, 91 (4): 1351-7. 10.1172/JCI116336.CrossRefPubMedPubMedCentral
28.
go back to reference Sesso HD, Wang L, Buring JE, Ridker PM, Gaziano JM: Comparison of interleukin-6 and C-reactive protein for the risk of developing hypertension in women. Hypertension. 2007, 49 (2): 304-10. 10.1161/01.HYP.0000252664.24294.ff.CrossRefPubMed Sesso HD, Wang L, Buring JE, Ridker PM, Gaziano JM: Comparison of interleukin-6 and C-reactive protein for the risk of developing hypertension in women. Hypertension. 2007, 49 (2): 304-10. 10.1161/01.HYP.0000252664.24294.ff.CrossRefPubMed
29.
go back to reference Savoia C, Schiffrin EL: Inflammation in hypertension. Curr Opin Nephrol Hypertens. 2006, 15 (2): 152-8. 10.1097/01.mnh.0000203189.57513.76.PubMed Savoia C, Schiffrin EL: Inflammation in hypertension. Curr Opin Nephrol Hypertens. 2006, 15 (2): 152-8. 10.1097/01.mnh.0000203189.57513.76.PubMed
30.
go back to reference Boos CJ, Lip GY: Is hypertension an inflammatory process?. Curr Pharm Des. 2006, 12 (13): 1623-35. 10.2174/138161206776843313.CrossRefPubMed Boos CJ, Lip GY: Is hypertension an inflammatory process?. Curr Pharm Des. 2006, 12 (13): 1623-35. 10.2174/138161206776843313.CrossRefPubMed
31.
go back to reference Di Napoli M, Papa F: Systemic inflammation, blood pressure, and stroke outcome. J Clin Hypertens (Greenwich). 2006, 8 (3): 187-94. 10.1111/j.1524-6175.2005.04590.x.CrossRef Di Napoli M, Papa F: Systemic inflammation, blood pressure, and stroke outcome. J Clin Hypertens (Greenwich). 2006, 8 (3): 187-94. 10.1111/j.1524-6175.2005.04590.x.CrossRef
32.
go back to reference Kern PA, Ranganathan S, Li C, Wood L, Ranganathan G: Adipose tissue tumor necrosis factor and interleukin-6 expression in human obesity and insulin resistance. Am J Physiol Endocrinol Metab. 2001, 280 (5): E745-E751.PubMed Kern PA, Ranganathan S, Li C, Wood L, Ranganathan G: Adipose tissue tumor necrosis factor and interleukin-6 expression in human obesity and insulin resistance. Am J Physiol Endocrinol Metab. 2001, 280 (5): E745-E751.PubMed
33.
go back to reference Tsigos C, Kyrou I, Chala E, et al: Circulating tumor necrosis factor alpha concentrations are higher in abdominal versus peripheral obesity. Metabolism. 1999, 48 (10): 1332-5. 10.1016/S0026-0495(99)90277-9.CrossRefPubMed Tsigos C, Kyrou I, Chala E, et al: Circulating tumor necrosis factor alpha concentrations are higher in abdominal versus peripheral obesity. Metabolism. 1999, 48 (10): 1332-5. 10.1016/S0026-0495(99)90277-9.CrossRefPubMed
34.
go back to reference Dimitrov PS, Simeonov VA, Tsolova SD, Bonev AG, Georgieva RB, Karmaus WJ: Increased blood pressure in adult offspring of families with Balkan endemic nephropathy: a prospective study. BMC Nephrol. 2006, 7: 12-10.1186/1471-2369-7-12.CrossRefPubMedPubMedCentral Dimitrov PS, Simeonov VA, Tsolova SD, Bonev AG, Georgieva RB, Karmaus WJ: Increased blood pressure in adult offspring of families with Balkan endemic nephropathy: a prospective study. BMC Nephrol. 2006, 7: 12-10.1186/1471-2369-7-12.CrossRefPubMedPubMedCentral
35.
go back to reference Karmaus W, Dimitrov P, Simeonov V, Tsolova S, Batuman V: Offspring of parents with Balkan Endemic Nephropathy have higher C-reactive protein levels suggestive of inflammatory processes: a longitudinal study. BMC Nephrol. 2009, 10: 10-10.1186/1471-2369-10-10.CrossRefPubMedPubMedCentral Karmaus W, Dimitrov P, Simeonov V, Tsolova S, Batuman V: Offspring of parents with Balkan Endemic Nephropathy have higher C-reactive protein levels suggestive of inflammatory processes: a longitudinal study. BMC Nephrol. 2009, 10: 10-10.1186/1471-2369-10-10.CrossRefPubMedPubMedCentral
36.
go back to reference Fox ER, Benjamin EJ, Sarpong DF, et al: Epidemiology, heritability, and genetic linkage of C-reactive protein in African Americans (from the Jackson Heart Study). Am J Cardiol. 2008, 102 (7): 835-41. 10.1016/j.amjcard.2008.05.049.CrossRefPubMedPubMedCentral Fox ER, Benjamin EJ, Sarpong DF, et al: Epidemiology, heritability, and genetic linkage of C-reactive protein in African Americans (from the Jackson Heart Study). Am J Cardiol. 2008, 102 (7): 835-41. 10.1016/j.amjcard.2008.05.049.CrossRefPubMedPubMedCentral
Metadata
Title
The relation of C - reactive protein to chronic kidney disease in African Americans: the Jackson Heart Study
Authors
Ervin R Fox
Emelia J Benjamin
Daniel F Sarpong
Harsha Nagarajarao
Jason K Taylor
Michael W Steffes
Abdullah K Salahudeen
Michael F Flessner
Ermeg L Akylbekova
Caroline S Fox
Robert J Garrison
Herman A Taylor Jr
Publication date
01-12-2010
Publisher
BioMed Central
Published in
BMC Nephrology / Issue 1/2010
Electronic ISSN: 1471-2369
DOI
https://doi.org/10.1186/1471-2369-11-1

Other articles of this Issue 1/2010

BMC Nephrology 1/2010 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.